GENEIUS

Geneius Biotechnology is a T cell immunotherapy company focused on therapies for cancer. There is growing evidence for the potential of T cell immunotherapy for successful treatment of cancer patients. Our proprietary approach is distinct and unique from other T cell immunotherapy approaches and promotes the surveillance and destruction of cancer cells by the immune system. Through a transformative academic collaboration we are rapidly translating products from bench to bedside. We are currently developing products for both hematologic and solid cancers through our academic collaboration and expect to start clinical trials by the end of the year.